
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA‐128 and modulating MAPK1
Mei Xu, Kai Zhou, Yuanzhe Wu, et al.
Molecular Carcinogenesis (2018) Vol. 58, Iss. 4, pp. 577-587
Closed Access | Times Cited: 47
Mei Xu, Kai Zhou, Yuanzhe Wu, et al.
Molecular Carcinogenesis (2018) Vol. 58, Iss. 4, pp. 577-587
Closed Access | Times Cited: 47
Showing 1-25 of 47 citing articles:
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
Э. А. Брага, М. В. Фридман, Alexey A. Moscovtsev, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8855-8855
Open Access | Times Cited: 196
Э. А. Брага, М. В. Фридман, Alexey A. Moscovtsev, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8855-8855
Open Access | Times Cited: 196
A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
Xin Jin, Yuhang Liu, Jia Zhang, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 2, pp. 315-325
Closed Access | Times Cited: 104
Xin Jin, Yuhang Liu, Jia Zhang, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 2, pp. 315-325
Closed Access | Times Cited: 104
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 11
Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma
Rui Zhou, Ka Wu, Min Su, et al.
Environmental Toxicology and Pharmacology (2019) Vol. 70, pp. 103200-103200
Closed Access | Times Cited: 63
Rui Zhou, Ka Wu, Min Su, et al.
Environmental Toxicology and Pharmacology (2019) Vol. 70, pp. 103200-103200
Closed Access | Times Cited: 63
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma
Lina You, Qinwen Tai, Lin Xu, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 6, pp. 719-736
Open Access | Times Cited: 47
Lina You, Qinwen Tai, Lin Xu, et al.
Cancer Gene Therapy (2021) Vol. 28, Iss. 6, pp. 719-736
Open Access | Times Cited: 47
LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465
Hui Zhao, Aixia Wang, Zhiwei Zhang
The Journal of Biochemistry (2020) Vol. 168, Iss. 2, pp. 171-181
Open Access | Times Cited: 40
Hui Zhao, Aixia Wang, Zhiwei Zhang
The Journal of Biochemistry (2020) Vol. 168, Iss. 2, pp. 171-181
Open Access | Times Cited: 40
Paeonol inhibits the malignancy of Apatinib-resistant gastric cancer cells via LINC00665/miR-665/MAPK1 axis
Ming Li, Ou Cai, Yuanjie Yu, et al.
Phytomedicine (2021) Vol. 96, pp. 153903-153903
Closed Access | Times Cited: 35
Ming Li, Ou Cai, Yuanjie Yu, et al.
Phytomedicine (2021) Vol. 96, pp. 153903-153903
Closed Access | Times Cited: 35
Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells
Wu Wu, Li Guo, Zhenlong Liang, et al.
Journal of Cancer (2020) Vol. 11, Iss. 8, pp. 2201-2212
Open Access | Times Cited: 37
Wu Wu, Li Guo, Zhenlong Liang, et al.
Journal of Cancer (2020) Vol. 11, Iss. 8, pp. 2201-2212
Open Access | Times Cited: 37
The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Aída Barreiro-Alonso, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1020-1020
Open Access | Times Cited: 35
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Aída Barreiro-Alonso, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1020-1020
Open Access | Times Cited: 35
A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation
Chao Wu, Zhihong Huang, Ziqi Meng, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 32
Chao Wu, Zhihong Huang, Ziqi Meng, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 32
Role of lncRNAHCP5/microRNA-525–5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells
Ling Wang, Miao He, Li Fu, et al.
Experimental Cell Research (2020) Vol. 394, Iss. 1, pp. 112129-112129
Closed Access | Times Cited: 31
Ling Wang, Miao He, Li Fu, et al.
Experimental Cell Research (2020) Vol. 394, Iss. 1, pp. 112129-112129
Closed Access | Times Cited: 31
Exosomal lncRNAs in the Tumor Angiogenesis: As Therapeutic Targets in Cancer Treatment
Chou‐Yi Hsu, Farag M. A. Altalbawy, Enwa Felix Oghenemaro, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Closed Access
Chou‐Yi Hsu, Farag M. A. Altalbawy, Enwa Felix Oghenemaro, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Closed Access
HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer
Jiahong Jiang, Shaohai Wang, Zehua Wang, et al.
Cancer Chemotherapy and Pharmacology (2020) Vol. 86, Iss. 2, pp. 295-305
Closed Access | Times Cited: 25
Jiahong Jiang, Shaohai Wang, Zehua Wang, et al.
Cancer Chemotherapy and Pharmacology (2020) Vol. 86, Iss. 2, pp. 295-305
Closed Access | Times Cited: 25
PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1
Ming Wang, Qin Liao, Pengfei Zou
Cancer Biology & Therapy (2020) Vol. 21, Iss. 4, pp. 364-371
Open Access | Times Cited: 24
Ming Wang, Qin Liao, Pengfei Zou
Cancer Biology & Therapy (2020) Vol. 21, Iss. 4, pp. 364-371
Open Access | Times Cited: 24
Long non-coding RNA NEAT1 facilitates the growth, migration, and invasion of ovarian cancer cells via the let-7 g/MEST/ATGL axis
Lili Yin, Yu Wang
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Lili Yin, Yu Wang
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Role of exosomal non‑coding RNAs in ovarian cancer (Review)
Xinchen Wang, Yang Miao, Jiamei Zhu, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 4
Closed Access | Times Cited: 3
Xinchen Wang, Yang Miao, Jiamei Zhu, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 4
Closed Access | Times Cited: 3
Long noncoding RNA LINC00473 functions as a competing endogenous RNA to regulate MAPK1 expression by sponging miR-198 in breast cancer
Ligang Niu, Yuhui Zhou, Wei Zhang, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 8, pp. 152470-152470
Closed Access | Times Cited: 24
Ligang Niu, Yuhui Zhou, Wei Zhang, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 8, pp. 152470-152470
Closed Access | Times Cited: 24
LncRNA HORAS5 Promotes Taxane Resistance in Castration-Resistant Prostate Cancer via a BCL2A1-Dependent Mechanism
Perla Pucci, Erik Venalainen, Ilaria Alborelli, et al.
Epigenomics (2020) Vol. 12, Iss. 13, pp. 1123-1138
Closed Access | Times Cited: 21
Perla Pucci, Erik Venalainen, Ilaria Alborelli, et al.
Epigenomics (2020) Vol. 12, Iss. 13, pp. 1123-1138
Closed Access | Times Cited: 21
Role of microRNAs in glycolysis in gynecological tumors (Review)
Qianying Chen, Siyi Shen, Nengyuan Lv, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 5
Open Access | Times Cited: 8
Qianying Chen, Siyi Shen, Nengyuan Lv, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 5
Open Access | Times Cited: 8
Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma
Valeria Ferretti, Ignácio E. León
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 17
Valeria Ferretti, Ignácio E. León
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 17
Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers
Ba Da Yun, Ye Ji Choi, Seung Wan Son, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 930-930
Open Access | Times Cited: 12
Ba Da Yun, Ye Ji Choi, Seung Wan Son, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 930-930
Open Access | Times Cited: 12
Identification of Co-expressed Genes Between Atrial Fibrillation and Stroke
Yanfei Zhang, Ling‐bing Meng, Meng-lei Hao, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 18
Yanfei Zhang, Ling‐bing Meng, Meng-lei Hao, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 18
The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
Hua Lan, Jing Yuan, Da Zeng, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Hua Lan, Jing Yuan, Da Zeng, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancer
Ghaidaa Raheem Lateef Al‐Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, et al.
Future Oncology (2022) Vol. 18, Iss. 38, pp. 4209-4231
Closed Access | Times Cited: 11
Ghaidaa Raheem Lateef Al‐Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, et al.
Future Oncology (2022) Vol. 18, Iss. 38, pp. 4209-4231
Closed Access | Times Cited: 11
Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis
Yuanyuan Liu, Xiaomin Fu, Xiuyun Wang, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 14
Yuanyuan Liu, Xiaomin Fu, Xiuyun Wang, et al.
Molecular Medicine Reports (2021) Vol. 23, Iss. 5
Open Access | Times Cited: 14